Men with prostate cancer who take the cholesterol-lowering drugs known as statins are significantly less likely to die from their cancer than men who do not take such medication, according to a new study.
An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones. This study adds long-term survival and safety data for the drug tasquinimod, a new candidate for treating advanced and recurrent prostate cancer.
Fish oil consumption affects levels of pro-inflammatory molecules, omega fatty acids, measure of cancer growth.
Vesicles released from aggressive prostate cancer cells with highly migratory features, known as large oncosomes, may be a new source of biomarkers for aggressive prostate cancer.
Men with prostate cancer who ate a low-fat diet and took fish oil supplements had lower levels of proinflammatory substances in their blood than men who ate a typical Western diet.
This fact sheet reviews common sites of cancer metastasis, methods of spread, treatment, and additional details.
Cancer of the prostate gland is the most common cancer affecting men. This fact sheet can help patients learn more about screening and risk factors.
This patient fact sheet answers some commonly asked questions about prostate cancer and bone health. It also discusses steps you can take to care for your bones.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|